The number of IL-10+B cells in SSc patients is very low, especially in those with SSc-related interstitial lung disease (ILD); furthermore, the number of IL-10+B cells is negatively correlated with the number of IL-17A-producing T cells, suggesting that IL-10 plays an important negative regulatory role in the pathogenesis of SSc. Here, IL17A is linked to systemic sclerosis.